Genetic causes and gene-nutrient interactions in mammalian zinc deficiencies: Acrodermatitis enteropathica and transient neonatal zinc deficiency as examples

Journal of Trace Elements in Medicine and Biology

Volumn 29, Issue , 2015, Pages 47-62

  Kasana, Shakhenabat ^a   Din, Jamila ^a   Maret, Wolfgang ^a  

^a KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

Acrodermatitis enteropathica; Nutritional zinc deficiency; Transient neonatal zinc deficiency; Zinc; Zinc transporters

Indexed keywords

8 QUINOLINOL; 8 QUINOLINOL DERIVATIVE; AMPHOTERICIN B; CLIOQUINOL; DIIODOHYDROXYQUIN; PROTEIN ZIP4; UNCLASSIFIED DRUG; ZINC REGULATED TRANSPORTER 1; ZINC SULFATE; ZINC TRANSPORTER; CATION TRANSPORT PROTEIN; ZINC;

ACRODERMATITIS ENTEROPATHICA; BLINDNESS; DIET SUPPLEMENTATION; DRUG STRUCTURE; ENZYME REGULATION; GENE CONTROL; GENE EXPRESSION; GENE FUNCTION; GENE INTERACTION; GENE LOCATION; GENE MUTATION; GENETIC TRANSCRIPTION; HEREDITY; HUMAN; INTESTINE CELL; NONHUMAN; OPTIC NERVE ATROPHY; PHENOTYPE; PROTEIN FUNCTION; PROTEIN TRANSPORT; REVIEW; RISK FACTOR; SKIN CELL; SUBACUTE MYELOOPTIC NEUROPATHY; TRANSIENT NEONATAL ZINC DEFICIENCY; VITAMIN SUPPLEMENTATION; ZINC DEFICIENCY; ZINC METABOLISM; ZIP4 GENE; ZNT2 GENE; ACRODERMATITIS; AMINO ACID SEQUENCE; ANIMAL; BREAST MILK; CHEMISTRY; DEFICIENCY; DISEASE MODEL; DISORDERS OF METAL METABOLISM; FOOD; GENETIC PREDISPOSITION; GENETICS; MAMMAL; METABOLISM; MOLECULAR GENETICS;

MAMMALIA;

ACRODERMATITIS; AMINO ACID SEQUENCE; ANIMALS; CATION TRANSPORT PROTEINS; DISEASE MODELS, ANIMAL; FOOD; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MAMMALS; METAL METABOLISM, INBORN ERRORS; MILK, HUMAN; MOLECULAR SEQUENCE DATA; ZINC;

EID: 84977787492     PISSN: 0946672X     EISSN: 18783252     Source Type: Journal    
DOI: 10.1016/j.jtemb.2014.10.003     Document Type: Review

References (166)

1. Wende G.W. Epidermolysis bullosa hereditaria. J Cutan Diseases 1902, 20:537-547.
2. MacLeod J.M.H. Skin diseases due to monilia and other yeast like fungi. Br J Dermatol 1930, 42:549.
3. Hopkins J.G. Moniliasis and monilids. Arch Dermat & Syph 1932, 25:599-614.
4. Schlutz F.W. Systemic thrush in childhood. JAMA 1935, 105:650-653.
5. Baird K.H. Unusual syndrome associated with Candida albicans infection. Pediatrics 1949, 4:730-734.
6. Brandt T. Dermatitis in children with disturbances of the general condition and the absorption of food elements. Acta Dermat-Venereol 1936, 17:513.
7. Danbolt N. Acrodermatitis enteropathica. Br J Dermatol 1979, 100:37-40.
8. Dillaha C., Lorincz A., Aavik O. Acrodermatitis enteropathica. Review of the literature and report of a case successfully treated with diodoquin. JAMA 1953, 152:509-512.
9. Danbolt N., Closs K. Acrodermatitis enteropathica. Acta Dermat-Venereol 1942, 23:127-169.
10. Bloom D., Sobel N. Acrodermatitis enteropathica successfully treated with diodoquin. J Invest Dermatol 1955, 24:167-177.
11. Piraccini B.M., Fanti P.A., Morelli R. Hallopeau's acrodermatitis continua of the nail apparatus: a clinical and pathological study of 20 patients. Acta Dermat-Venereol 1994, 74:65-67.
12. Aggett P.J., Delves H.T., Harries J.T., Bangham A.D. The possible role of diodoquin as a zinc ionophore in the treatment of acrodermatitis enteropathica. Biochem Biophys Res Commun 1979, 87:513-517.
13. Berggren L., Hansson O. Treating acrodermatitis enteropathica. Lancet 1966, 1:52.
14. Rubin I.L., Hansen J.D.L., Goldberg B., Presbury D.C.G., Kilroe-Smith T.A. Acrodermatitis enteropathica - a zinc deficiency state. S Afr Med J 1978, 53:497-498.
15. Barnes P., Moynahan E. Zinc deficiency in acrodermatitis enteropathica: multiple dietary intolerances treated with synthetic diet. Proc R Soc Med 1973, 66:327-329.
16. Moynahan E.J. Acrodermatitis enteropathica: a lethal inherited human zinc-deficiency disorder. Lancet 1974, 2:399-400.
17. Westall R.G. Dietary treatment of a child with maple syrup urine disease. Arch Dis Child 1963, 38:485-491.
18. Mann T.P., Wilson K.M., Clayton B.E. A deficiency state arising in infants on synthetic food. Arch Dis Child 1965, 40:364-375.
19. Clayton B.E., Arthur A.B., Francis D.E.M. Early dietary management of sugar intolerance in infancy. Br Med J 1966, 2:679.
20. Neldner K.H., Hambidge K.M. Zinc therapy of acrodermatitis enteropathica. Lancet 1975, 292:879-882.
21. Hambidge K.M., Neldner K.H., Walraven P.A. Letter: Zinc, acrodermatitis enteropathica, and congenital malformations. Lancet 1975, 305:577-578.
22. Delves H.T., Harries J.T., Lawson M.S., Mitchell J.D. Letter: Zinc and diodoquin in acrodermatitis enteropathica. Lancet 1975, 2:929.
23. Prasad A.S., Miale A., Farid Z., Sandstead H., Schulert A. Zinc metabolism in patients with syndrome of iron deficiency anemia, hepatosplenomegaly, dwarfism and hypogonadism. J Lab Clin Med 1963, 61:537-549.
24. Prasad A.S. Discovery of human zinc deficiency: its impact on human health and disease. Adv Nutr 2013, 4:176-190.
25. Prasad A., Halsted J., Nadimi M. Syndrome of iron deficiency anemia, hepatosplenomegaly, hypogonadism, dwarfism and geophagia. Am J Med 1961, 31:532-546.
26. Lombeck I., Schnippering H.G., Ritzl F., Feinendegen L.E., Bremer H.J. Letter: Absorption of zinc in acrodermatitis enteropathica. Lancet 1975, 305:855.
27. Lombeck I., von Bassewitz D.B., Becker K. Ultrastructural findings in acrodermatitis enteropathica. Pediatr Res 1974, 8:82-88.
28. Atherton D.J., Muller D.P., Aggett P.J., Harries J.T. A defect in zinc uptake by jejunal biopsies in acrodermatitis enteropathica. Clin Sci 1979, 56:505-507.
29. Casey C.E., Hambidge K.M., Walravens P.A., Silverman A., Neldner K.H. Zinc binding in human duodenal secretion. Lancet 1978, 312:423.
30. Evans G.W., Johnson P.E. Defective prostaglandin synthesis in acrodermatitis enteropathica. Lancet 1977, 309:52.
31. Song M.K., Adham N.F. Evidence for an important role of prostaglandin E2 and F2 in the regulation of zinc transport in the rat. J Nutr 1979, 109:2152-2159.
32. Lonnerdal B., Stanislowski A.G., Hurley L.S. Isolation of a low molecular weight zinc binding ligand from human milk. J Inorg Biochem 1980, 12:71-78.
33. Evans G.W., Johnson P.E. Characterization and quantitation of a zinc-binding ligand in human milk. Pediatr Res 1980, 14:876-880.
34. Starcher B.C., Glauber J.G., Madaras J.G. Zinc absorption and its relationship to intestinal metallothionein. J Nutr 1980, 110:1391-1397.
35. Aggett P.J., Delves H.T., Thorn J.M., Atherton D.J., Harris J.T., Bangham A.D. The therapeutic effect of amphotericin in acrodermatitis enteropathica: hypothesis and implications. Eur J Pediatr 1981, 137:23-25.
36. Andreoli T.E. The structure and function of amphotericin B-cholesterol pores in lipid bilayer membranes. Ann NY Acad Sci 1974, 235:448-468.
37. Butler W.T., Bennett J.E., Alling D.W., Wertlake P.T., Utz J.P., Hill G. Nephrotoxicity of amphotericin B: early and late effects in 81 patients. Ann Intern Med 1964, 61:175-187.
38. Palmiter R.D., Findley S.D. Cloning and functional characterization of a mammalian zinc transporter that confers resistance to zinc. EMBO J 1995, 14:639-649.
39. Zhao H., Eide D. The yeast ZRT1 gene encodes the zinc transporter protein of a high-affinity uptake system induced by zinc limitation. Proc Natl Acad Sci USA 1996, 93:2454-2458.
40. Eide D., Broderius M., Fett J., Guerinot M.L. A novel iron-regulated metal transporter from plants identified by functional expression in yeast. Proc Natl Acad Sci USA 1996, 93:5624-5628.
41. Guerinot M.L. The ZIP family of metal transporters. Biochim Biophys Acta 2000, 1465:190-198.
42. Jeong J., Eide D.J. The SLC39 family of zinc transporters. Mol Aspects Med 2013, 34:612-619.
43. Lichten L.A., Cousins R.J. Mammalian zinc transporters: nutritional and physiologic regulation. Annu Rev Nutr 2009, 29:153-176.
44. Hogstrand C., Fu D. Zinc. Binding, transport and storage of metal ions in biological cells 2014, 666-694. Royal Society of Chemistry Press, Cambridge. W. Maret, A.G. Wedd (Eds.).
45. Grider A., Mouat M.F. The acrodermatitis enteropathica mutation affects protein expression in human fibroblasts: analysis by two-dimensional gel electrophoresis. J Nutr 1998, 128:1311-1314.
46. Muga S.J., Grider A. Partial characterization of a human zinc-deficiency syndrome by differential display. Biol Trace Elem Res 1999, 68:1-12.
47. Wang K., Pugh E.W., Griffen S., Doheny K.F., Mostafa W.Z., Al-Aboosi M.M., et al. Homozygosity mapping places the acrodermatitis enteropathica gene on the chromosomal region 8q24.3. Am J Hum Genet 2001, 68:1055-1060.
48. Wang K., Zhou B., Kuo Y.M., Zemansky J., Gitschier J. A novel member of a zinc transporter family is defective in acrodermatitis enteropathica. Am J Hum Genet 2002, 71:66-73.
49. Kury S., Dreno B., Bezieau S., Giraudet S., Kharfi M., Kamoun R., et al. Identification of SLC39A4, a gene involved in acrodermatitis enteropathica. Nat Genet 2002, 31:239-240.
50. Gaither L.A., Eide D.J. Eukaryotic zinc transporters and their regulation. Biometals 2001, 14:251-270.
51. Taylor K.M., Nicholson R.I. The LZT proteins; the LIV-1 subfamily of zinc transporters. Biochim Biophys Acta 2003, 1611:16-30.
52. Antala S., Dempski R.E. The human ZIP-4 transporter has two distinct bonding affinities and mediates transport of multiple transition metals. Biochemistry 2012, 51:963-973.
53. Kambe T., Andrews G. Novel proteolytic processing of the ectodomain of the zinc transporter ZIP4 (SLC39A4) during zinc deficiency is inhibited by acrodermatitis enteropathica mutations. Mol Cell Biol 2009, 29:129-139.
54. Andrews G.K. Regulation and function of ZIP-4, the acrodermatitis enteropathica gene. Biochem Soc Trans 2008, 36:1242-1246.
55. Weaver B.P., Dufner-Beattie J., Kambe T., Andrews G.K. Novel zinc-responsive post-transcriptional mechanisms reciprocally regulate expression of the mouse Slc39a4 and Slc39a5 zinc transporters (Zip4 and Zip5). Biol Chem 2007, 388:1301-1312.
56. Maverakis E., Fung M., Lynch P., Draznin M., Michael D., Ruben B., et al. Acrodermatitis enteropathica and an overview of zinc metabolism. J Am Acad Dermatol 2007, 56:116-124.
57. Dufner-Beattie J., Wang F., Kuo Y., Gitschier J., Eide D., Andrews G.K. The Acrodermatitis enteropathica gene ZIP4 encodes a tissue-specific, zinc-regulated zinc transporter in mice. J Biol Chem 2003, 278:33474-33481.
58. Dufner-Beattie J., Kuo Y.M., Gitschier J., Andrews G.K. The adaptive response to dietary zinc in mice involves the differential cellular localization and zinc regulation of the zinc transporters ZIP4 and ZIP5. J Biol Chem 2004, 279:49082-49090.
59. Huang Z., Dufner-Beattie J., Andrews G.K. Expression and regulation of SLC39A family zinc transporters in the developing mouse intestine. Dev Biol 2006, 295:571-579.
60. 2+-stimulated endocytosis of the mZIP4 zinc transporter regulates its location at the plasma membrane. J Biol Chem 2004, 279:4523-4530.
61. Mao X., Kim B., Wang F., Eide D., Petris M. A histidine-rich cluster mediates the ubiquitination and degradation of the human zinc transporter hZIP4, and protects against zinc cytotoxicity. J Biol Chem 2007, 282:6992-7000.
62. Schmitt S., Küry S., Giraud M., Dréno B., Kharfi M., Bézieau S. An update on mutations of the SLC39A4 gene in acrodermatitis enteropathica. Hum Mutat 2009, 30:926-933.
63. Jung A.G., Mathony U.A., Behre B., Kury S., Schmitt S., Zouboulis C.C., et al. Acrodermatitis enteropathica: an uncommon differential diagnosis in childhood - first description of a new sequence variant. J Dtsch Dermatol Ges 2011, 9:999-1002.
64. Li C.R., Yan S.M., Shen D.B., Li Q., Shao J.P., Xue C.Y., et al. One novel homozygous mutation of SLC39A4 gene in a Chinese patient with acrodermatitis enteropathica. Arch Dermatol Res 2010, 302:315-317.
65. Takeichi T., Nanda A., Liu L., Salam A., Campbell P., Fong K., et al. Impact of next generation sequencing on diagnostics in a genetic skin disease clinic. Exp Dermatol 2013, 22:825-831.
66. Nakano H., Nakamura Y., Kawamura T., Shibagaki N., Matsue H., Aizu T., et al. Novel and recurrent nonsense mutation of the SLC39A4 gene in Japanese patients with acrodermatitis enteropathica. Br J Dermatol 2009, 161:184-186.
67. Vardi A., Anikster Y., Eisenkraft A., Shohat M., Abu-Much J., Eisenkraft S., et al. A new genetic isolate of acrodermatitis enteropathica with a novel mutation. Br J Dermatol 2009, 160:1346-1348.
68. Coromilas A., Brandling-Bennett H.A., Morel K.D., Chung W.K. Novel SLC39A4 mutation in acrodermatitis enteropathica. Pediatr Dermatol 2011, 28:697-700.
69. Santiago F., Matos J., Moreno A., Schmitt S., Bezieau S., Tellechea O. Acrodermatitis enteropathica: a novel SLC39A4 gene mutation found in a patient with an early-onset. Pediatr Dermatol 2011, 28:735-736.
70. Park C.H., Lee M.J., Kim H.J., Lee G., Park J.W., Cinn Y.W. Congenital zinc deficiency from mutations of the SLC39A4 gene as the genetic background of acrodermatitis enteropathica. J Korean Med Sci 2010, 25:1818-1820.
71. Kilic M., Taskesen M., Coskun T., Gurakan F., Tokatli A., Sivri H.S., et al. Zinc sulphate-resistant acrodermatitis enteropathica patient with a novel mutation in SLC39A4 gene. JIMD Rep 2012, 2:25-28.
72. Van Wouwe J.P. Clinical and laboratory assessment of zinc deficiency in Dutch children: a review. Biol Trace Elem Res 1995, 49:211-225.
73. Wang F., Kim B.E., Dufner-Beattie J., Petris M.J., Andrews G., Eide D.J. Acrodermatitis enteropathica mutations affect transport activity, localization and zinc-responsive trafficking of the mouse ZIP4 zinc transporter. Hum Mol Genet 2004, 13:563-571.
74. Ackland M., Michalczyk A. Zinc deficiency and its inherited disorders - a review. Genes Nutr 2006, 1:41-49.
75. Geiser J., Venken K.J.T., De Lisle R.C., Andrews G.K. A mouse model of acrodermatitis enteropathica: loss of intestine zinc transporter ZIP4 (Slc39a4) disrupts the stem cell niche and intestine integrity. PLoS Genet 2012, 8:1-16. (e1002766).
76. Kury S., Kharfi M., Kamoun R., Taieb A., Mallet E., Baudon J.J., et al. Mutation spectrum of human SLC39A4 in a panel of patients with acrodermatitis enteropathica. Hum Mutat 2003, 22:337-338.
77. Dufner-Beattie J., Weaver B., Geiser J., Bilgen M., Larson M., Xu W., et al. The mouse acrodermatitis enteropathica gene Slc39a4 (Zip4) is essential for early development and heterozygosity causes hypersensitivity to zinc deficiency. Hum Mol Genet 2007, 16:1391-1399.
78. Engelken J., Carnero-Montoro E., Pybus M., Andrews G.K., Lalueza-Fox C., Comas D., et al. Extreme population differences in the human zinc transporter ZIP4 (SLC39A4) are explained by positive selection in Sub-Saharan Africa. PLoS Genet 2014, 10:1-14. (e1004128).
79. Kharfi M., El Fekih N., Aounallah-Skhiri H., Schmitt S., Fazaa B., Kury S., et al. Acrodermatitis enteropathica: a review of 29 Tunisian cases. Int J Dermatol 2010, 49:1038-1044.
80. Nakano A., Nakano H., Nomura K., Toyomaki Y., Hanada K. Novel SLC39A4 mutations in acrodermatitis enteropathica. J Invest Dermatol 2003, 120:963-966.
81. Meftah S.P., Kuivaniemi H., Tromp G., Kerkeni A., Sfar M.T., Ayadi A., et al. A new mutation in exon 3 of the SCL39A4 gene in a Tunisian family with severe acrodermatitis enteropathica. Nutrition 2006, 22:1067-1070.
82. Wang S., Xue L., Guo Z.P., Wang L., Yang Y. A novel SLC39A4 gene mutation in the family of an acrodermatitis enteropathica patient with an unusual presentation. Br J Dermatol 2008, 159:976-978.
83. Maret W. Zinc biochemistry: from a single zinc enzyme to a key element of life. Adv Nutr 2013, 4:82-91.
84. Haase H., Rink L. Multiple impacts of zinc on immune function. Metallomics 2014, 6:1175-1180.
85. Kienholz E.W., Turk D.E., Sunde M.L., Hoekstra W.G. Effects of zinc deficiency in the diets of hens. J Nutr 1961, 75:211-221.
86. Hurley L.S. Zinc deficiency in the developing rat. Am J Clin Nutr 1969, 22:1332-1339.
87. Dufner-Beattie J., Huang Z.L., Geiser J., Xu W., Andrews G.K. Generation and characterization of mice lacking the zinc uptake transporter ZIP3. Mol Cell Biol 2005, 25:5607-5615.
88. Dufner-Beattie J., Huang Z.L., Geiser J., Xu W., Andrews G.K. Mouse ZIP1 and ZIP3 genes together are essential for adaptation to dietary zinc deficiency during pregnancy. Genesis 2006, 44:239-251.
89. Sato T., van Es J.H., Snippert H.J., Stange D.E., Vries R.G. Paneth cells constitute the niche for Lgr5 stem cells in intestinal crypts. Nature 2011, 469:415-418.
90. Giblin L.J., Chang C.J., Bentley A.F., Frederickson C., Lippard S.J., Frederickson C.J. Zinc-secreting Paneth cells studied by ZP fluorescence. J Histochem Cytochem 2006, 54:311-316.
91. Bohane T.D., Cutz E., Hamilton J.R., Gall D.G. Acrodermatitis enteropathica, zinc, and the Paneth cell. Gastroenterology 1977, 73:587-592.
92. Braun O.H., Heilmann K., Rossne J.A., Pauli W., Bergmann K.E. Acrodermatitis enteropathica. II. Zinc deficiency and ultrastructural findings. Eur J Pediatr 1977, 125:153-162.
93. Gwyn-Joncs J., Elmes M.E., Aggett P.J., Harries J.T. The effect of zinc therapy on lysosomal inclusion bodies in intestinal epithelial cells in acrodermatitis enteropathica. Pediatr Res 1983, 17:354-357.
94. Mack D., Koletzko B., Cunnane S., Cutz E., Griffiths A. Acrodermatitis enteropathica with normal serum zinc levels: diagnostic value of small bowel biopsy and essential fatty acid determination. Gut 1989, 30:1426-1429.
95. Kawamura T., Ogawa Y., Nakamura Y., Nakamizo S., Ohta Y., Nakano H., et al. Severe dermatitis with loss of epidermal Langerhans cells in human and mouse zinc deficiency. J Clin Invest 2012, 122:722-732.
96. Yuzbasiyan-Gurkan V., Bartlett E. Identification of a unique splice site variant in SLC39A4 in bovine hereditary zinc deficiency, lethal trait A46: an animal model of acrodermatitis enteropathica. Genomics 2006, 88:521-526.
97. Brummerstedt E., Basse A., Flagstad T., Andresen E. Animal model: Lethal A46 in cattle (hereditary parakeratosis, hereditary thymic hypoplasia, hereditary zinc deficiency). Am J Pathol 1977, 87:725-728.
98. McPherson E.A., Beattis I.S., Young G.B. Inherited defect in Friesian calves. Nord Veterinaermed 1964, 16:533-540.
99. Chesters J.K. Zinc metabolism in animals: pathology, immunology and genetics. J Inherit Metab Dis 1983, 6:34-38.
100. White S.D., Bourdeau P., Rosychuk R.A., Cohen B., Bonenberger T., Fieseler K.V., et al. Zinc responsive dermatosis in dogs: 41 cases and literature review. Vet Dermatol 2001, 12:101-109.
101. Krametter-Froetscher R., Hauser S., Baumgartner W. Zinc-responsive dermatosis in goats suggestive of hereditary malabsorption: two field cases. Vet Dermatol 2005, 16:269-275.
102. Grider A., Mouat M.F., Mauldin E.A., Casal M.L. Analysis of the liver soluble proteome from bull terriers affected with inherited lethal acrodermatitis. Mol Genet Metab 2007, 92:249-257.
103. Ford D. Intestinal and placental zinc transport pathways. Proc Nutr Soc 2004, 63:21-29.
104. Wang X., Zhou B. Dietary zinc absorption: A play of Zips and ZnTs in the gut. IUBMB Life 2010, 62:176-182.
105. Weaver B.P., Andrews G.K. Regulation of zinc-responsive Slc39a5 (Zip5) translation is mediated by conserved elements in the 3'-untranslated region. Biometals 2012, 25:319-335.
106. Geiser J., De Lisle R.C., Andrews G.K. The zinc transporter Zip5 (Slc39a5) regulates intestinal zinc excretion and protects the pancreas against zinc toxicity. PLoS One 2013, 8(11):e82149.
107. McMahon R.J., Cousins R.J. Regulation of the zinc transporter ZnT1 by dietary zinc. Proc Natl Acad Sci USA 1998, 95:4841-4846.
108. Cragg R.A., Phillips S.R., Piper J.M., Varma J.S., Campbell F.C., Mathers J.C., et al. Homeostatic regulation of zinc transporters in the human small intestine by dietary zinc supplementation. Gut 2005, 54:469-478.
109. Valentine R.A., Jackson K.A., Christie G.R., Mathers J.C., Taylor P.M., Ford D. ZnT5 variant B is a bidirectional zinc transporter and mediates zinc uptake in human intestinal Caco-2 cells. J Biol Chem 2007, 282:14389-14393.
110. Kaler P., Prasad R. Molecular cloning and functional characterization of novel zinc transporter rZip10 (Slc39a10) involved in zinc uptake across rat renal brush-border membrane. Am J Physiol Renal Physiol 2007, 292:F217-F229.
111. Aggett P.J., Atherton D.J., More J., Davey J., Delves H.T., Harries J.T. Symptomatic zinc deficiency in a breast-fed preterm infant. Arch Dis Child 1980, 55:547-550.
112. Zimmerman A.W., Hambidge K.M., Lepow M.L., Greenberg R.D., Stover M.L., Casey C.E. Acrodermatitis in breast-fed premature infants: evidence for a defect of mammary zinc secretion. Pediatrics 1982, 69:176-183.
113. Lopez V., Kelleher S.L. Zinc transporter-2 (ZnT2) variants are localized to distinct subcellular compartments and functionally transport zinc. Biochem J 2009, 422:43-52.
114. McCormick N.H., Hennigar S.R., Kiselyov K., Kelleher S.L. The biology of zinc transport in mammary epithelial cells: implications for mammary gland development, lactation, and involution. J Mammary Gland Biol Neoplasia 2014, 19:59-71.
115. Seo Y.A., Lee S., Hennigar S.R., Kelleher S.L. PRL-stimulated ubiquitination of ZnT2 mediates a transient increase in Zn secretion followed by ZnT2 degradation in mammary epithelial cells. J Biol Chem 2014, 289:23653-23661.
116. Qian L., Lopez V., Seo Y.A., Kelleher S.L. Prolactin regulates ZnT2 expression through the JAK2/STAT5 signaling pathway in mammary cells. Am J Physiol Cell Physiol 2009, 297:C369-C377.
117. Lasry I., Seo Y.A., Ityel H., Shalva N., Pode-Shakked B., Glaser F., et al. Dominant negative heterozygous G87R mutation in the zinc transporter, ZnT2 (SLC30A2), results in transient neonatal zinc deficiency. J Biol Chem 2012, 287:29348-29361.
118. Qian L., Wang B., Tang N., Zhang W., Cai W. Polymorphisms of SLC30A2 and selected perinatal factors associated with low milk zinc in Chinese breastfeeding women. Early Hum Dev 2012, 88:663-668.
119. Chowanadisai W., Lonnerdal B., Kelleher S.L. Identification of a mutation in SCL30A2 (ZnT-2) in women with low milk zinc concentration that results in transient neonatal zinc deficiency. J Biol Chem 2006, 281:39699-39707.
120. Seo Y.A., Lopez V., Kelleher S.L. A histidine-rich motif mediates mitochondrial localization of ZnT2 to modulate mitochondrial function. Am J Physiol Cell Physiol 2011, 300:C1479-C1489.
121. Lasry I., Golan Y., Berman B., Amram N., Glaser F., Assaraf Y.G. In Situ dimerization of multiple wild type and mutant zinc transporters in live cells using bimolecular fluorescence complementation. J Biol Chem 2014, 289:7275-7292.
122. Itsumura N., Inamo Y., Okazaki F., Teranishi F., Narita H. Compound heterozygous mutations in SLC30A2/ZnT2 results in low milk zinc concentrations: a novel mechanism for zinc deficiency in a breast-fed infant. PLoS One 2013, 8(5):e64045.
123. Navarro M.L., Casano A.V., Lopez C.B., Ballesteros M.D.F., Diaz D.J.G., Erchiga A.C., et al. Transient neonatal zinc deficiency due to a new autosomal dominant mutation in gene SLC30A2 (ZnT2). Pediatr Dermatol 2014, 31:251-252.
124. Piletz J.E., Ganschow R.E. Zinc deficiency in murine milk underlies expression of the lethal milk (lm) mutation. Science 1978, 199:181-183.
125. Huang L., Gitschier J. A novel gene involved in zinc transport is deficient in the lethal milk mouse. Nat Genet 1997, 17:292-297.
126. Fukada T., Kambe T. Molecular and genetic features of zinc transporters in physiology and pathogenesis. Metallomics 2011, 3:662-674.
127. Wouwe J. Clinical and laboratory diagnosis of acrodermatitis enteropathica. Eur J Pediatr 1989, 149:2-8.
128. Dorea J.G. Zinc in human milk. Nutr Res 2000, 20:1645-1687.
129. Bates C.J., Tsuchiya H. Zinc in breast milk during prolonged lactation: Comparison between the UK and The Gambia. Eur J Clin Nutr 1990, 44:61-69.
130. Cheshire H., Stather P., Vorster J. Acquired acrodermatitis enteropathica due to zinc deficiency in a patient with pre-existing Darier's disease. J Dermatol Case Rep 2009, 3:41-43.
131. Changela A., Javaiya H., Changela K., Davanos E., Rickenbach K. Acrodermatitis enteropathica during adequate enteral nutrition. J Parenter Enteral Nutr 2012, 36:235-237.
132. Kim S.T., Kang J.S., Baek J.W., Kim T.K., Lee J.W., Jeon Y.S., et al. Acrodermatitis enteropathica with anorexia nervosa. J Dermatol 2010, 37:726-729.
133. Bae-Harboe Y.S., Solky A., Masterpol K.S. A case of acquired zinc deficiency. Dermatol Online J 2012, 18:1.
134. Macdonald J.B., Connolly S.M., DiCaudo D.J. Think zinc deficiency: acquired acrodermatitis enteropathica due to poor diet and common medications. Arch Dermatol 2012, 148:961-963.
135. Quirk C.M., Seykora J., Wingate B.J., Cotsarelis G. Acrodermatitis enteropathica associated with anorexia nervosa. JAMA 2002, 288:2655-2656.
136. Van Voorhees A.S., Riba M. Acquired zinc deficiency in association with anorexia nervosa: case reports and review of the literature. Pediatr Dermatol 1992, 9:268-271.
137. Chaudhry A.A., Warthan M.M., Pariser R.J., Hood A.F. Acquired acrodermatitis enteropathica secondary to alcoholism. Cutis 2008, 82:60-62.
138. Lowe N.M., Fekete K., Decsi T. Methods of assessment of zinc status in humans: a systematic review. Am J Clin Nutr 2009, 89:2040S-2051S.
139. Roohani N., Hurrell R., Kelishadi R., Schulin R. Zinc and its importance for human health: an integrative review. J Res Med Sci 2013, 18:144-157.
140. Sandstead H.H., Prasad A.S., Penland J.G., Beck F.W., Kaplan J., Egger N.G., et al. Zinc deficiency in Mexican American children: influence of zinc and other micronutrients on T cell, cytokines, and anti-inflammatory plasma proteins. Am J Clin Nutr 2008, 88:1067-1073.
141. Chen M.D., Song Y.M. An infant with acrodermatitis enteropathica like symptoms but without hypozincemia. Pediatr Dermatol 2005, 22:280-281.
142. Tatlican S., Yamangokturk B., Eren C., Gulbahar O., Eskioglu F. A diagnostic challenge: a case of acrodermatitis enteropathica without hypozincemia and with maternal milk of low zinc level. Pediatr Dermatol 2010, 27:534-535.
143. Lee S.Y., Jung Y.J., Oh T.H., Choi E.H. A case of acrodermatitis enteropathica localized on the hands and feet with a normal serum zinc level. Ann Dermatol 2011, 23:S88-S90.
144. Lim Y.S., Lee M.W., Choi J.H., Sung K.J. The clinical study of zinc deficiency presented as a skin manifestation of acrodermatitis enteropathica. Korean J Dermatol 2000, 38:155-162.
145. Maret W., Sandstead H.H. Zinc requirements and the risks and benefits of zinc supplementation. J Trace Elem Med Biol 2006, 20:3-18.
146. Murthy S.C., Udagani M.M., Badakali A.V., Yelameli B.C. Symptomatic zinc deficiency in a full-term breast-fed infant. Dermatol Online J 2010, 16:3.
147. Sturtevant F.M. Zinc deficiency, acrodermatitis enteropathica, optic atrophy, subacute myelo-optic neuropathy, and 5,7-dihalo-8-quinolinols. Pediatrics 1980, 65:610-613.
148. Der Kaloustian V.M., Musallam S.S., Sanjad S.A., Murib A., Hammad W.D., Idriss Z.H. Oral treatment of acrodermatitis enteropathica with zinc sulphate. Am J Dis Child 1976, 130:42-43.
149. Gartside J.M., Allen B.R. Treatment of acrodermatitis enteropathica with zinc sulphate. Br Med J 1975, 3:521-522.
150. Yang Y., Jing X-P., Zhang S-P., Gu R-X., Tang F-X., Wang X-L., et al. High dose zinc supplementation induces hippocampal zinc deficiency and memory impairment with inhibition of BDNF signaling. PLoS One 2013, 8:1-9. (e55384).
151. Seok S.H., Cho W.S., Park J.S., Na Y., Jang A., Kim H., et al. Rat pancreatitis produced by 13-week administration of zinc oxide nanoparticles: biopersistence of nanoparticles and possible solutions. J Appl Toxicol 2013, 33:1089-1096.
152. Blundell R., Adam F. Haemolytic anaemia and acute pancreatitis associated with zinc toxicosis in a dog. Vet Rec 2013, 172:17.
153. Dhawan S.S., Ryder K.M., Pritchard E. Massive penny ingestion: the loot with local and systemic effects. J Emerg Med 2008, 35:33-37.
154. Doherty K., Connor M., Cruickshank R. Zinc-containing denture adhesive: a potential source of excess zinc resulting in copper deficiency myelopathy. Br Dent J 2011, 210:523-525.
155. Kelleher S.L., Lonnerdal B. Zinc supplementation reduces iron absorption through age-dependent changes in small intestine iron transporter expression in suckling rat pups. J Nutr 2006, 136:1185-1191.
156. Geiser J., De Lisle R.C., Finkelstein D., Adlard P.A., Bush A.I., Andrews G.K. Clioquinol synergistically augments rescue by zinc supplementation in a mouse model of acrodermatitis enteropathica. PLoS One 2013, 8:1-10. (e72543).
157. Afrin L.B. Fatal copper deficiency from excess use of zinc-based denture adhesive. Am J Med Sci 2010, 340:164-168.
158. Adlard P.A., Bush A.I. Metal chaperones: a holistic approach to the treatment of Alzheimer's disease. Front Psychiatry 2012, 3:1-5.
159. Cui X., Zhang Y., Yang J., Sun X., Hagan J.P., Guha S., et al. ZIP4 confers resistance to zinc deficiency-induced apoptosis in pancreatic cancer. Cell Cycle 2014, 13:1180-1186.
160. Xu X., Guo H.J., Xie H.Y., Li J., Zhuang R.Z., Ling Q., et al. A novel determinant of tumor invasion in hepatocellular carcinoma, contributes to tumor recurrence after liver transplantation. Int J Biol Sci 2014, 10:245-256.
161. Bostanci Z., Alam S., Soybel D.I., Kelleher S.L. Prolactin receptor attenuation induces zinc pool redistribution through ZnT2 and decreases invasion in MDA-MB-453 breast cancer cells. Exp Cell Res 2014, 321:190-200.
162. Kambe T., Hashimoto A., Fujimoto S. Current understanding of ZIP and ZnT zinc transporters in human health and diseases. Cell Mol Life Sci 2014, 71:3281-3295.
163. Maret W. Zinc and human disease. Interrelations between essential metal ions and human diseases, Vol. 13 of Metal ions in life sciences 2013, 389-414. Springer Science+Business Media B.V, Dordrecht, The Netherlands. L. Sigel, H. Sigel, R.K.O. Sigel (Eds.).
164. Chimienti F. Zinc, pancreatic islet cell function and diabetes: new insights into an old story. Nutr Res Rev 2013, 26:1-11.
165. Maret W. A role for metallothionein in the pathogenesis of diabetes and its cardiovascular complications. Mol Genet Metab 2008, 94:1-3.
166. Hao Q., Maret W. Imbalance between pro-oxidant and pro-antioxidant functions of zinc in disease. J Alzheimer's Dis 2005, 8:161-170.